SCHEMBL7149514

SCHEMBL7149514

NS(=O)(=O)CCCCCCl

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.42
CA1 P00915 7/20 0.42
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CA9 Q16790 6/20 0.31
CA12 O43570 2/20 0.31
CA3 P07451 2/20 0.31
CA4 P22748 2/20 0.31
CA6 P23280 2/20 0.31
CA5A P35218 2/20 0.31
CA7 P43166 2/20 0.31
CA14 Q9ULX7 2/20 0.31
CA5B Q9Y2D0 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11099870 1.00 CA2 (0.42) CA2CA1ALDH1A1TSHRCYP4F2
SCHEMBL9302678 1.00 CA2 (0.42) CA2CA1ALDH1A1TSHRCYP4F2
SCHEMBL7103948 1.00 CA2 (0.42) CA2CA1ALDH1A1TSHRCYP4F2
SCHEMBL3858379 0.97
SCHEMBL249264 0.88
SCHEMBL11147913 0.85 CA2 (0.48) CA2CA1CA9CA12CA3
SCHEMBL8069056 0.85 CA2 (0.48) CA2CA1CA9CA12CA3
SCHEMBL30041571 0.85 CA2 (0.48) CA2CA1CA9CA12CA3
SCHEMBL10798852 0.85 CA2 (0.48) CA2CA1CA9CA12CA3
SCHEMBL10457263 0.82 CA2 (0.43) CA2CA1TSHRCA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9956293-B2 Targeted therapeutics MADRIGAL PHARMACEUTICALS, INC. (US) 2018-05-01 US disclosed
US-9956293-B2 Targeted therapeutics MADRIGAL PHARMACEUTICALS, INC. (US) 2018-05-01 US disclosed
US-9597343-B2 Targeted therapeutics SYNTA PHARMACEUTICALS CORP. (US) 2017-03-21 US disclosed
US-9597343-B2 Targeted therapeutics SYNTA PHARMACEUTICALS CORP. (US) 2017-03-21 US disclosed
EP-1020443-B1 PROCESS FOR PRODUCING PIPERAZINESULFONAMIDE DERIVATIVES AND SALTS THEREOF AZWELL INC (JP) 2003-09-10 EP disclosed
EP-1020437-A1 PROCESS FOR PRODUCING HALOGENOALKYLSULFONAMIDE DERIVATIVES Azwell Inc. (JP) 2000-07-19 EP disclosed
US-5705494-A INDUCED BY ADMINISTERING; COMBAT SIDE EFFECTS OF GLUCOCORTICOIDS ROUSSEL-UCLAF (FR) 1998-01-06 US disclosed
US-5679788-A ANTIESTEROGENIC AGENT ROUSSEL UCLAF (FR) 1997-10-21 US disclosed
EP-0629635-B1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them ROUSSEL UCLAF (FR) 1997-03-19 EP disclosed
US-5556845-A ANTIESTROGEN ROUSSEL UCLAF (FR) 1996-09-17 US disclosed
US-5494907-A ANTIESTROGEN ACTIVITY ROUSSEL UCLAF (FR) 1996-02-27 US disclosed
EP-0381132-B1 Imidazopyridazines, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-03-08 EP disclosed
EP-0629635-A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them ROUSSEL UCLAF (FR) 1994-12-21 EP disclosed
US-5202324-A Bronchodilators TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-04-13 US disclosed
EP-0381132-A1 Imidazopyridazines, their production and use Takeda Chemical Industries, Ltd. (JP) 1990-08-08 EP disclosed